Corona News Bulletins
Tuesday, 4 January 2022
Why Biogen's Alzheimer's drug Aduhelm is so controversial
Biogen's Alzheimer's drug Aduhelm was heralded as a historic triumph against the memory-robbing disease. Now, the company is trying to keep it afloat.
from Health and Science https://ift.tt/3FXTPVX
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment